Celldex Therapeutics has halted work on its solid-tumor-focused bispecific as the biotech prioritizes its work in ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed ...

Campaigning is set to conclude tomorrow for the first phase of polling in Jharkhand, where 43 assembly constituencies will ...

MannKind (MNKD) announced the successful completion of its first-in-human Phase 1 study of nintedanib DPI, or MNKD-201, for pulmonary fibrotic ...

Cavite Extension project is set to open later this month, the Department of Transportation (DoTr) said on Thursday. In a ...

Line 1 Cavite Extension is set to open this November, Transportation Secretary Jaime Bautista confirmed on Thursday. In a ...

Transportation Secretary Jaime Bautista on Thursday announced the partial opening of the first segment of LRT-1 Cavite ...

The study is evaluating AJ1-11095, a novel agent for the treatment of myelofibrosis that did not respond to or relapsed ...

Diving deeper into the financial backgrounds of the candidates, the report by Jharkhand Election Watch and the Association ...

Lexeo Therapeutics (LXEO) announced positive interim results from the Phase 1/2 study of LX1001 for the treatment of APOE4-associated ...

Bright Minds Biosciences' BMB-101 shows promise in treating drug-resistant epilepsy. Read why DRUG stock is a strong ...

Amrita Vishwa Vidyapeetham has announced dates for the first phase of the Amrita Entrance Examination – Engineering (AEEE) ...